Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

101 (47%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2018-02-21 1769
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2017-04-03 2018-02-21 5223
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-16 2018-05-30 43168
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2024-12-13 2025-02-28 245612
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-02-06 2025-05-08 249731
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-04-10 250906
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2025-04-02 2025-04-10 253963
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-02 256462
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-08 256465
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-08 256468
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-17 2021-01-21 130291
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-28 2021-02-05 132639
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135974
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135977
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135980
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-25 2021-04-21 136341
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-18 199554
TEVA-QUININE 200MG CAPSULE Resolved 2020-05-01 2020-06-18 113735
TEVA-QUININE 300MG CAPSULE Resolved 2020-05-29 2020-07-23 116168
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626